Effects of Filter Ventilation on Sensory Response, Smoking Topography, and Inhalation in Current Every Day Cigarette Smokers
NCT ID: NCT04060446
Last Updated: 2022-07-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
8 participants
OBSERVATIONAL
2019-06-06
2020-03-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COMET2 Project 1 Filter Ventilation Study
NCT03637972
COMET Study 1: Filter Ventilated Cigarette Substitution in the ETM
NCT03306173
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
NCT06816459
Evaluation of Cessation Preferences of Menthol Smoker
NCT02020005
Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II
NCT00734617
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To assess the link between marketing proxies for filter ventilation (product descriptors, packaging) and risk beliefs.
OUTLINE:
Patients smoke 5 cigarettes separated by 30 minute washout periods. Between 48 hours and 1 week later, patients smoke another 5 cigarettes separated by 30 minute washout period with CReSSMicro topography measurement device and BioRadio device for recording inhalation patterns.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational (smoke cigarettes)
Patients smoke 5 cigarettes separated by 30 minute washout periods. Between 48 hours and 1 week later, patients smoke another 5 cigarettes separated by 30 minute washout period with CReSSMicro topography measurement device and BioRadio device for recording inhalation patterns.
Medical Device
Smoke cigarettes with CReSSMicro topography measurement device and BioRadio device
Questionnaire Administration
Ancillary studies
Tobacco Smoking
Smoke cigarettes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medical Device
Smoke cigarettes with CReSSMicro topography measurement device and BioRadio device
Questionnaire Administration
Ancillary studies
Tobacco Smoking
Smoke cigarettes
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primarily using factory-made filtered cigarettes with filter ventilation
* Fair and above physical health
* Fair and above mental health
* Not actively trying to quit smoking or planning to quit in the next 30 days
* Able to converse, read, and write in English
* No alcohol or illegal drug use
* Not pregnant or breastfeeding
Exclusion Criteria
* Using roll-your-own cigarettes or unventilated filter cigarettes
* Currently using any other tobacco product daily
* Actively trying to quit smoking or planning to quit in the next 30 days
* Not able to converse, read, and write in English
* Adults unable to consent
* Prisoners
* Poor physical health by self report
* Poor mental health by self report
* Alcohol and illegal drug use
* Pregnant or breastfeeding by self report
18 Years
69 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Minnesota
OTHER
Roswell Park Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard J O'Connor
Role: PRINCIPAL_INVESTIGATOR
Roswell Park Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Roswell Park Cancer Institute
Buffalo, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2019-04530
Identifier Type: REGISTRY
Identifier Source: secondary_id
I 68718
Identifier Type: OTHER
Identifier Source: secondary_id
I 68718
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.